These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32980240)

  • 1. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
    Shi Y; Luan D; Song R; Zhang Z
    Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.
    Sharma AN; da Costa e Silva BF; Soares JC; Carvalho AF; Quevedo J
    J Affect Disord; 2016 Jun; 197():9-20. PubMed ID: 26956384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the association between depression, suicidality and serum neurotrophin levels in adolescents.
    Bilgiç A; Çelikkol Sadıç Ç; Kılınç İ; Akça ÖF
    Int J Psychiatry Clin Pract; 2020 Jun; 24(2):143-150. PubMed ID: 32027188
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotrophic factors, clinical features and gender differences in depression.
    de Azevedo Cardoso T; Mondin TC; Wiener CD; Marques MB; Fucolo Bde Á; Pinheiro RT; de Souza LD; da Silva RA; Jansen K; Oses JP
    Neurochem Res; 2014 Aug; 39(8):1571-8. PubMed ID: 24899094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
    Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
    Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophic factors in depression in response to treatment.
    Buttenschøn HN; Foldager L; Elfving B; Poulsen PH; Uher R; Mors O
    J Affect Disord; 2015 Sep; 183():287-94. PubMed ID: 26047306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder.
    Amidfar M; Réus GZ; de Moura AB; Quevedo J; Kim YK
    Adv Exp Med Biol; 2021; 1305():257-272. PubMed ID: 33834404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
    Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML
    J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression.
    Nomoto H; Baba H; Satomura E; Maeshima H; Takebayashi N; Namekawa Y; Suzuki T; Arai H
    BMC Psychiatry; 2015 Mar; 15():33. PubMed ID: 25885038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.
    Carvalho AF; Köhler CA; McIntyre RS; Knöchel C; Brunoni AR; Thase ME; Quevedo J; Fernandes BS; Berk M
    Psychoneuroendocrinology; 2015 Dec; 62():18-26. PubMed ID: 26210676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD.
    Liu X; Li P; Ma X; Zhang J; Sun X; Luo X; Zhang Y
    J Affect Disord; 2022 Oct; 315():190-197. PubMed ID: 35908604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.
    Ibrahim L; Duncan W; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    Brain Res Bull; 2011 Aug; 86(1-2):129-33. PubMed ID: 21704134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression.
    Satomura E; Baba H; Nakano Y; Maeshima H; Suzuki T; Arai H
    J Affect Disord; 2011 Dec; 135(1-3):332-5. PubMed ID: 21774990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.
    Emon MPZ; Das R; Nishuty NL; Shalahuddin Qusar MMA; Bhuiyan MA; Islam MR
    BMC Res Notes; 2020 Feb; 13(1):83. PubMed ID: 32085720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood.
    Madsen CA; Navarro ML; Elfving B; Kessing LV; Castrén E; Mikkelsen JD; Knudsen GM
    Eur Neuropsychopharmacol; 2024 Oct; 87():35-55. PubMed ID: 39079257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.
    Tu KY; Wu MK; Chen YW; Lin PY; Wang HY; Wu CK; Tseng PT
    Medicine (Baltimore); 2016 Jan; 95(4):e2411. PubMed ID: 26825882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.